SeaCrest Wealth Management LLC Has $427,000 Stake in iShares Biotechnology ETF (NASDAQ:IBB)

SeaCrest Wealth Management LLC lowered its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 68.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,233 shares of the financial services provider’s stock after selling 6,980 shares during the period. SeaCrest Wealth Management LLC’s holdings in iShares Biotechnology ETF were worth $427,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. BNP Paribas Financial Markets raised its holdings in iShares Biotechnology ETF by 29.3% in the 3rd quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock worth $346,561,000 after acquiring an additional 538,899 shares during the period. Healthcare of Ontario Pension Plan Trust Fund grew its position in shares of iShares Biotechnology ETF by 32.9% in the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock valued at $96,533,000 after purchasing an additional 164,000 shares during the last quarter. Aprio Wealth Management LLC bought a new position in shares of iShares Biotechnology ETF in the fourth quarter worth about $18,476,000. Aristides Capital LLC acquired a new position in shares of iShares Biotechnology ETF during the 2nd quarter worth about $9,180,000. Finally, Sanctuary Advisors LLC bought a new stake in iShares Biotechnology ETF during the 2nd quarter valued at approximately $8,118,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 0.3 %

Shares of NASDAQ IBB opened at $132.96 on Friday. iShares Biotechnology ETF has a 12 month low of $123.60 and a 12 month high of $150.57. The business’s 50 day moving average is $137.24 and its two-hundred day moving average is $141.87.

iShares Biotechnology ETF Cuts Dividend

The business also recently announced a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were given a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.